The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Theraputics Inc. (ACRS) | COM | 00461U105 | 11,420 | 634,455 | SH | SOLE | 634,455 | 0 | 0 | ||
| Aeglea Biotherapeutics Inc. (AGLE) | COM | 00773J103 | 13,445 | 1,691,151 | SH | SOLE | 1,691,151 | 0 | 0 | ||
| Atreca Inc. (BCEL) | CL A COM | 04965G109 | 2,415 | 387,653 | SH | SOLE | 387,653 | 0 | 0 | ||
| AVROBIO, Inc. (AVRO) | COM | 05455M100 | 5,635 | 1,009,779 | SH | SOLE | 1,009,779 | 0 | 0 | ||
| Biomea Fusion Inc. (BMEA) | COM | 09077A106 | 9,561 | 798,757 | SH | SOLE | 798,757 | 0 | 0 | ||
| BridgeBio Pharma Inc. (BBIO) | COM | 10806X102 | 284,413 | 6,068,125 | SH | SOLE | 6,068,125 | 0 | 0 | ||
| Elevation Oncology Inc. (ELEV) | COM | 28623U101 | 22,084 | 2,834,910 | SH | SOLE | 2,834,910 | 0 | 0 | ||
| Harmony Biosciences Holdings Inc. (HRMY) | COM | 413197104 | 22,723 | 592,815 | SH | SOLE | 592,815 | 0 | 0 | ||
| Marker Therapeutics, Inc. (MRKR) | COM | 57055L107 | 5,311 | 3,142,857 | SH | SOLE | 3,142,857 | 0 | 0 | ||
| Monte Rosa Therapeutics Inc. (GLUE) | COM | 61225M102 | 32,804 | 1,472,331 | SH | SOLE | 1,472,331 | 0 | 0 | ||
| Nabriva Therapeutics plc (NBRV) | SHS | G63637113 | 227 | 191,028 | SH | SOLE | 191,028 | 0 | 0 | ||
| Nuvation Bio Inc. (NUVB) | COM CL A | 67080N101 | 25,258 | 2,541,009 | SH | SOLE | 2,541,009 | 0 | 0 | ||
| ObsEva SA (OBSV) | COM | H5861P103 | 4,312 | 1,386,338 | SH | SOLE | 1,386,338 | 0 | 0 | ||
| Poseida Therapeutics Inc. (PSTX) | COM | 73730P108 | 7,605 | 1,043,267 | SH | SOLE | 1,043,267 | 0 | 0 | ||
| Viracta Therapeutics Inc. (VIRX) | COM | 92765F108 | 2,314 | 288,571 | SH | SOLE | 288,571 | 0 | 0 | ||
| Verona Pharma plc (VRNA) | SPONSORED ADS | 925050106 | 7,302 | 1,332,485 | SH | SOLE | 1,332,485 | 0 | 0 | ||
| Zosano Pharma Corporation (ZSAN) | COM NEW | 98979H202 | 1,956 | 2,718,226 | SH | SOLE | 2,718,226 | 0 | 0 | ||
| Reneo Pharmaceuticals Inc. (RPHM) | COM | 75974E103 | 6,601 | 886,075 | SH | SOLE | 886,075 | 0 | 0 | ||
| Syndax Pharmaceuticals, Inc. (SNDX) | COM | 87164F105 | 19,588 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | ||
| Spruce Biosciences, Inc. (SPRB) | COM | 85209E109 | 7,245 | 1,205,511 | SH | SOLE | 1,205,511 | 0 | 0 | ||
| Talaris Therapeutics Inc. (TALS) | COM | 87410C104 | 9,260 | 682,923 | SH | SOLE | 682,923 | 0 | 0 | ||